DSM acquires US-based biotechnology firm Microbia

22 September 2010 08:29  [Source: ICIS news]

SINGAPORE (ICIS)--DSM has acquired US-based biotechnology research and development firm Microbia for an undisclosed fee, the Netherlands-based chemicals specialty materials and life sciences producer said on Wednesday.

The acquisition would allow DSM to incorporate Microbia’s proprietary platform and research, which would support the company’s ongoing development of the natural carotenoids market, it said in a statement.

Carotenoids are anti-oxidant chemicals that exist in the pigment that colours plants.

Microbia owns technology which allows the firm to produce “high-quality, natural carotenoids nutritional products and other specialty materials and chemicals from renewable resources,” the statement said.

"The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes," added Leendert Staal, president and CEO of DSM Nutritional Products.

Microbia is a majority-owned subsidiary of US-based drug maker Ironwood Pharmaceuticals.

To discuss issues facing the chemical industry go to ICIS connect

By: Nurluqman Suratman

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly